Legends of Figure
Figure 1. Maternal humoral immune response following infection with SARS-CoV-2 according to time from infection to delivery
(A) The rate of pregnant women with positive serum anti-spike IgG (IgG-S), anti-spike IgM (IgM-S) and anti-nucleocapsid IgG (IgG-N) antibodies over time (weeks) from infection.
(B) LOESS smooth curve (smoothing parameter 0.4) of mean antibody levels according to time between COVID-19 disease and delivery (weeks). Antibodies levels were normalized by dividing each value with the highest value measured. Anti-spike antibodies were also multiplied by 3 in order to fit the scale. Antibody levels below the seropositivity threshold are shown as zero. Note that the graph represents the rate of antibody level decline and not their actual values.
Reference List
(1) Kumar M, Al Khodor S. Pathophysiology and treatment strategies for COVID-19. J Transl Med 2020; 18(1):353.
(2) Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9(1):386-389.
(3) Achiron A, Gurevich M, Falb R, Dreyer-Alster S, Sonis P, Mandel M. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects. Clin Microbiol Infect 2021.
(4) Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395(10226):809-815.
(5) Breslin N, Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM 2020; 2(2):100118.
(6) Chen Y, Peng H, Wang L, Zhao Y, Zeng L, Gao H et al. Infants Born to Mothers With a New Coronavirus (COVID-19). Front Pediatr 2020; 8:104.
(7) Li N, Han L, Peng M, Lv Y, Ouyang Y, Liu K et al. Maternal and Neonatal Outcomes of Pregnant Women With Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case-Control Study. Clin Infect Dis 2020; 71(16):2035-2041.
(8) Wang L, Shi Y, Xiao T, Fu J, Feng X, Mu D et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition). Ann Transl Med 2020; 8(3):47.
(9) Fan C, Lei D, Fang C, Li C, Wang M, Liu Y et al. Perinatal Transmission of 2019 Coronavirus Disease-Associated Severe Acute Respiratory Syndrome Coronavirus 2: Should We Worry? Clin Infect Dis 2021; 72(5):862-864.
(10) Baud D, Greub G, Favre G, Gengler C, Jaton K, Dubruc E et al. Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection. JAMA 2020; 323(21):2198-2200.
(11) Penfield CA, Brubaker SG, Limaye MA, Lighter J, Ratner AJ, Thomas KM et al. Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples. Am J Obstet Gynecol MFM 2020; 2(3):100133.
(12) Algarroba GN, Rekawek P, Vahanian SA, Khullar P, Palaia T, Peltier MR et al. Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy. Am J Obstet Gynecol 2020; 223(2):275-278.
(13) Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during Pregnancy and Possible Vertical Transmission. Am J Perinatol 2020; 37(8):861-865.
(14) Dong L, Tian J, He S, Zhu C, Wang J, Liu C et al. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn. JAMA 2020; 323(18):1846-1848.
(15) Zamaniyan M, Ebadi A, Aghajanpoor S, Rahmani Z, Haghshenas M, Azizi S. Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection. Prenat Diagn 2020; 40(13):1759-1761.
(16) Ferrazzi E, Frigerio L, Savasi V, Vergani P, Prefumo F, Barresi S et al. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis. BJOG 2020; 127(9):1116-1121.
(17) Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W et al. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA 2020; 323(18):1848-1849.
(18) Saadaoui M, Kumar M, Al Khodor S. COVID-19 Infection during Pregnancy: Risk of Vertical Transmission, Fetal, and Neonatal Outcomes. J Pers Med 2021; 11(6).
(19) Kotlyar AM, Grechukhina O, Chen A, Popkhadze S, Grimshaw A, Tal O et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 224(1):35-53.
(20) Novazzi F, Cassaniti I, Piralla A, Di Sabatino A, Bruno R, Baldanti F. SARS-CoV-2 positivity in rectal swabs: implication for possible transmission. J Glob Antimicrob Resist 2020; 22:754-755.
(21) Valdes G, Neves LA, Anton L, Corthorn J, Chacon C, Germain AM et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta 2006; 27(2-3):200-207.
(22) Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod 2020; 26(6):367-373.
(23) Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020; 222(6):521-531.
(24) Aghaeepour N, Ganio EA, Mcilwain D, Tsai AS, Tingle M, Van Gassen S et al. An immune clock of human pregnancy. Sci Immunol 2017; 2(15).
(25) Enninga EA, Nevala WK, Creedon DJ, Markovic SN, Holtan SG. Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. Am J Reprod Immunol 2015; 73(3):251-262.